[Combination therapy of chronic bacterial prostatitis]
- PMID: 28247621
[Combination therapy of chronic bacterial prostatitis]
Abstract
The article discusses the possible etiological factors in the development of chronic bacterial prostatitis. The authors presented a comparative long-term analysis of morbidity from non-viral sexually transmitted infections (STIs) in Russia. Against the background of general decline in STIs incidence, a significant percentage of them is made up by urogenital trichomoniasis. The findings substantiated the advantages of combination therapy (ornidazole and ofloxacin) for bacterial urinary tract infections.
Keywords: chronic prostatitis; infections; ofloxacin; ornidazole; sexually transmitted infections; therapy.
Similar articles
-
[Treatment of chronic bacterial prostatitis].Nihon Rinsho. 2002 Dec;60 Suppl 11:441-5. Nihon Rinsho. 2002. PMID: 12599616 Review. Japanese. No abstract available.
-
[Chronic prostatitis and biofilm].Infez Med. 2009 Jun;17 Suppl 1:10-6. Infez Med. 2009. PMID: 19696557 Italian.
-
The perspectives of the application of phage therapy in chronic bacterial prostatitis.FEMS Immunol Med Microbiol. 2010 Nov;60(2):99-112. doi: 10.1111/j.1574-695X.2010.00723.x. Epub 2010 Aug 3. FEMS Immunol Med Microbiol. 2010. PMID: 20698884 Review.
-
[Efficacy of low-intensity laser radiation and antibacterial therapy in the treatment of chronic prostatitis in the presence of sexually transmitted infections].Urologiia. 2007 May-Jun;(3):50-4, 56. Urologiia. 2007. PMID: 17724830 Clinical Trial. Russian.
-
Management of Chronic Bacterial Prostatitis.Curr Urol Rep. 2020 Jun 3;21(7):29. doi: 10.1007/s11934-020-00978-z. Curr Urol Rep. 2020. PMID: 32488742 Review.
Cited by
-
Pharmacological Interventions for Bacterial Prostatitis.Front Pharmacol. 2020 Apr 30;11:504. doi: 10.3389/fphar.2020.00504. eCollection 2020. Front Pharmacol. 2020. PMID: 32425775 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical